Clinical Trial Update: R115777 in Treating Patients With Advanced Bladder Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial of R115777 (tipifarnib) for advanced bladder cancer and related transitional cell cancers of the renal pelvis and ureter has completed. The snippe…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bladder Cancer
• Transitional Cell Carcinoma of the Renal Pelvis
• Transitional Cell Carcinoma of the Ureter

Drugs mentioned

• R115777 (tipifarnib)

Snippet

Sponsor: H. Lee Moffitt Cancer Center and Research Institute | Conditions: Bladder Cancer, Transitional Cell Cancer of the Renal Pelvis and Ureter | Phase 2 | Status: COMPLETED